# Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas

> **NCT01040559** · PHASE1 · COMPLETED · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 18 (estimated)

## Conditions studied

- Carcinoma, Hepatocellular

## Interventions

- **DRUG:** idarubicin

## Key facts

- **NCT ID:** NCT01040559
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2011-12
- **Final completion:** 2012-06
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2013-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01040559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01040559, "Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01040559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*